URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Robert Asbury

TitleClinical Professor
InstitutionSchool of Medicine and Dentistry
DepartmentMedicine
AddressInterlakes Oncology & Hematology, PC
211 White Spruce Blvd.
Rochester NY 14623
Other Positions
TitleClinical Professor
InstitutionUniversity of Rochester Medical Center
DepartmentCancer Center

 
 Selected Publications
List All   |   Timeline
  1. Asbury RF, Brunetto VL, Lee RB, Reid G, Rocereto TF. Goserelin acetate as treatment for recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Am J Clin Oncol. 2002 Dec; 25(6):557-60.
    View in: PubMed
  2. Chang AY, Rubins J, Asbury R, Boros L, Hui LF. Weekly paclitaxel in advanced non-small cell lung cancer. Semin Oncol. 2001 Aug; 28(4 Suppl 14):10-3.
    View in: PubMed
  3. Asbury RF, Lipsitz S, Graham D, Falkson CI, Baez L, Benson AB. Treatment of squamous cell esophageal cancer with topotecan: an Eastern Cooperative Oncology Group Study (E2293). Am J Clin Oncol. 2000 Feb; 23(1):45-6.
    View in: PubMed
  4. Novik Y, Ryan LM, Haller DG, Asbury R, Dutcher JP, Schutt A. Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282. Med Oncol. 1999 Dec; 16(4):261-6.
    View in: PubMed
  5. Tester WJ, Kim KM, Krigel RL, Bonomi PD, Glick JH, Asbury RF, Kirkwood JM, Blum RH, Schiller JH. A randomized Phase II study of interleukin-2 with and without beta-interferon for patients with advanced non-small cell lung cancer: an Eastern Cooperative Oncology Group study (PZ586). Lung Cancer. 1999 Sep; 25(3):199-206.
    View in: PubMed
  6. Ramanathan RK, Lipsitz S, Asbury RF, Qazi R, Greenberg BR, Haller DG. Phase II trial of trimetrexate for patients with advanced gastric carcinoma: an Eastern Cooperative Oncology Group study (E1287). Cancer. 1999 Aug 15; 86(4):572-6.
    View in: PubMed
  7. Chang AY, Hui L, Asbury R, Boros L, Garrow G, Rubins J. Ifosfamide, carboplatin and etoposide (ICE) in metastatic and refractory breast cancer. Cancer Chemother Pharmacol. 1999; 44 Suppl:S26-8.
    View in: PubMed
  8. Witte RS, Lipsitz S, Goodman TL, Asbury RF, Wilding G, Strnad CM, Smith TJ, Haller DG. A phase II trial of homoharringtonine and caracemide in the treatment of patients with advanced large bowel cancer. Invest New Drugs. 1999; 17(2):173-7.
    View in: PubMed
  9. Asbury R, Blessing JA, Reid GC, McGuire WP. A phase II trial of amonafide in patients with endometrial cancer: a Gynecologic Oncology Group Study. Am J Clin Oncol. 1998 Aug; 21(4):406-7.
    View in: PubMed
  10. Asbury R, Blessing JA, Podczaski E, Ball H. A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study. Am J Clin Oncol. 1998 Jun; 21(3):306-7.
    View in: PubMed
  11. Asbury R, Blessing JA, Buller R, Malfetano JH, Walker J, Sevin BU. Amonafide in patients with leiomyosarcoma of the uterus: a phase II Gynecologic Oncology Group study. Am J Clin Oncol. 1998 Apr; 21(2):145-6.
    View in: PubMed
  12. Asbury R, Blessing JA, Look KY, Buller R, Lucci JA. A phase II trial of amonafide in patients with nonsquamous cell carcinoma of the cervix. A Gynecologic Oncology Group study. Am J Clin Oncol. 1997 Dec; 20(6):626-7.
    View in: PubMed
  13. Chang AY, Boros L, Asbury R, Hui L, Rubins J. Dose-escalation study of weekly 1-hour paclitaxel administration in patients with refractory cancer. Semin Oncol. 1997 Oct; 24(5 Suppl 17):S17-69-S17-71.
    View in: PubMed
  14. Reisinger SA, Asbury R, Liao SY, Homesley HD. A phase I study of weekly cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: a Gynecologic Oncology Group pilot study. Gynecol Oncol. 1996 Dec; 63(3):299-303.
    View in: PubMed
  15. Asbury R, Blessing JA, Moore D. A phase II trail of aminothiadiazole in patients with mixed mesodermal tumors of the uterine corpus: a Gynecologic Oncology Group study. Am J Clin Oncol. 1996 Aug; 19(4):400-2.
    View in: PubMed
  16. Chang AY, Boros L, Garrow GC, Asbury RF, Hui L. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study. Semin Oncol. 1996 Jun; 23(3 Suppl 6):74-7.
    View in: PubMed
  17. Asbury R, Blessing JA, Smith DM, Carson LF. Aminothiadiazole in the treatment of advanced leiomyosarcoma of the uterine corpus. A Gynecologic Oncology Group study. Am J Clin Oncol. 1995 Oct; 18(5):397-9.
    View in: PubMed
  18. Chang AY, Boros L, Garrow G, Asbury R. Paclitaxel by 3-hour infusion followed by 96-hour infusion on failure in patients with refractory malignant disease. Semin Oncol. 1995 Jun; 22(3 Suppl 6):124-7.
    View in: PubMed
  19. Boros L, Garrow GC, Asbury RF, Chang AY. Phase I study of escalating doses of paclitaxel (Taxol) with fixed doses of ifosfamide, carboplatin, and etoposide. Semin Oncol. 1995 Jun; 22(3 Suppl 7):28-31.
    View in: PubMed
  20. Chang AY, Asbury RF, Boros L, Garrow GC, Hsieh S. Ifosfamide/carboplatin/etoposide chemotherapy in patients with metastatic non-small cell lung cancer. Semin Oncol. 1995 Jun; 22(3 Suppl 7):9-12.
    View in: PubMed
  21. Hsieh RK, Chang AY, Boros L, Asbury R. Phase II study of ifosfamide, carboplatin, and etoposide in patients with advanced non-small cell lung cancer. Am J Clin Oncol. 1994 Dec; 17(6):509-13.
    View in: PubMed
  22. Asbury RF, Blessing JA, Soper JT. A Gynecologic Oncology Group phase II study of amonafide (NSC #308847) in squamous cell carcinoma of the cervix. Am J Clin Oncol. 1994 Apr; 17(2):125-8.
    View in: PubMed
  23. Asbury RF, Cnaan A, Johnson L, Harris J, Zaentz SD, Haller DG. An Eastern Cooperative Oncology Group phase II study of single agent DHAD, VP-16, aclacinomycin, or spirogermanium in metastatic pancreatic cancer. Am J Clin Oncol. 1994 Apr; 17(2):166-9.
    View in: PubMed
  24. Asbury RF, Blessing JA, Look KY, Clarke-Pearson D, Homesley HD. A Gynecologic Oncology Group phase II study of amonafide (NSC 308847) in epithelial ovarian cancer. Am J Clin Oncol. 1993 Dec; 16(6):529-31.
    View in: PubMed
  25. Morrow GR, Asbury R, Hammon S, Dobkin P, Caruso L, Pandya K, Rosenthal S. Comparing the effectiveness of behavioral treatment for chemotherapy-induced nausea and vomiting when administered by oncologists, oncology nurses, and clinical psychologists. Health Psychol. 1992; 11(4):250-6.
    View in: PubMed
  26. Ransom DT, Neuberg D, Loprinzi CL, Tormey DC, Blum RH, Harris JE, Asbury RF, Falkson G. A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer. Am J Clin Oncol. 1991 Feb; 14(1):45-8.
    View in: PubMed
  27. Asbury RF, Blessing JA, McGuire WP, Hanjani P, Mortel R. Aminothiadiazole (NSC 4728) in patients with advanced carcinoma of the endometrium. A phase II study of the Gynecologic Oncology group. Am J Clin Oncol. 1990 Feb; 13(1):39-41.
    View in: PubMed
  28. Boros L, Peng YM, Alberts DS, Asbury RF, Goodman TL, Penn TE, Hickox DE. Pharmacokinetics of very high-dose oral melphalan in cancer patients. Am J Clin Oncol. 1990 Feb; 13(1):19-22.
    View in: PubMed
  29. Skeel RT, Andersen JW, Tormey DC, Benson AB, Asbury RF, Falkson G. Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group Study. Cancer. 1989 Oct 1; 64(7):1393-9.
    View in: PubMed
  30. Asbury RF, Blessing JA, DiSaia PJ, Malfetano J. Aminothiadiazole (NSC 4728) in patients with advanced nonsquamous carcinoma of the cervix. A phase II study of the Gynecologic Oncology Group. Am J Clin Oncol. 1989 Oct; 12(5):375-7.
    View in: PubMed
  31. Asbury RF, Kramer A, Green M, Qazi R, Skeel RT, Haller DG. A phase II study of carboplatin and CHIP in patients with metastatic colon carcinoma. Am J Clin Oncol. 1989 Oct; 12(5):416-9.
    View in: PubMed
  32. Chang AY, Bennett JM, Pandya KJ, Asbury R, McCune C. A study of aminoglutethemide and hydrocortisone in patients with advanced and refractory prostate carcinoma. Am J Clin Oncol. 1989 Aug; 12(4):358-60.
    View in: PubMed
  33. Amiraian R, Penn TE, Hamann S, Asbury RF, Boros L, Markowitch W, Goodman TL. Leukemic dermal infiltrates as a complication of central venous catheter placement. Cancer. 1988 Nov 15; 62(10):2223-5.
    View in: PubMed
  34. Pandya KJ, Kramar A, Asbury RF, Haller DG. A phase II study of spirogermanium in advanced large bowel cancer. An Eastern Cooperative Oncology Group study. Am J Clin Oncol. 1988 Aug; 11(4):496-8.
    View in: PubMed
  35. Chey RD, Lee KY, Asbury R, Chey WY. Effect of cisplatin on myoelectric activity of the stomach and small intestine in dogs. Dig Dis Sci. 1988 Mar; 33(3):338-44.
    View in: PubMed
  36. Asbury RF, Kramar A, Haller DG. Aminothiadiazole (NSC #4728) in patients with advanced colon cancer. A phase II study of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1987 Oct; 10(5):380-2.
    View in: PubMed
  37. Asbury RF, Blessing JA, Mortel R, Homesley HD, Malfetano J. Aminothiadiazole (NSC #4728) in patients with advanced cervical carcinoma. A phase II study of the Gynecologic Oncology Group. Am J Clin Oncol. 1987 Aug; 10(4):299-301.
    View in: PubMed
  38. Asbury RF, Boros L, Brower M, Woll J, Chang A, Bennett J. 5-Fluorouracil and high-dose folic acid treatment for metastatic colon cancer. Am J Clin Oncol. 1987 Feb; 10(1):47-9.
    View in: PubMed
  39. George TK, Fitzgerald D, Brown BS, Chuang C, Asbury RF, Boros L. Long-term survival in limited-stage small cell lung carcinoma. Experience in Rochester, New York from 1975 to 1981. Cancer. 1986 Sep 15; 58(6):1193-8.
    View in: PubMed
  40. Asbury RF, Wilson J, Blessing JA, Buchsbaum HJ, DiSaia PJ. Aminothiadiazole (NSC 4728) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group. Am J Clin Oncol. 1986 Aug; 9(4):334-6.
    View in: PubMed
  41. Pandya KJ, Chang AY, Qazi R, Rubins J, Asbury R. Combination chemotherapy for advanced colorectal cancer. A pilot study. Am J Clin Oncol. 1986 Feb; 9(1):31-4.
    View in: PubMed
  42. Wernz JC, Kao AK, Muggia FM, Asbury RF. Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma. Cancer Treat Rep. 1985 Feb; 69(2):223-4.
    View in: PubMed
  43. Muss HB, Asbury R, Bundy B, Ehrlich CE, Graham J. Mitoxantrone (NSC-301739) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology Group. Am J Clin Oncol. 1984 Dec; 7(6):737-9.
    View in: PubMed
  44. Asbury RF, Rubins J, Bennett JM. Etoposide in small cell lung cancer resistant to prior chemotherapy. Cancer Treat Rep. 1983 Oct; 67(10):951-2.
    View in: PubMed
  45. Morrow GR, Arseneau JC, Asbury RF, Bennett JM, Boros L. Anticipatory nausea and vomiting with chemotherapy. N Engl J Med. 1982 Feb 18; 306(7):431-2.
    View in: PubMed
  46. Asbury RF, Bakemeier RF, Fölsch E, McCune CS, Savlov E, Bennett JM. Treatment of metastatic breast cancer with aminoglutethimide. Cancer. 1981 Apr 15; 47(8):1954-8.
    View in: PubMed
  47. Asbury RF, Rosenthal SN, Descalzi ME, Ratcliffe RL, Arseneau JC. Hepatic veno-occlusive disease due to DTIC. Cancer. 1980 May 15; 45(10):2670-4.
    View in: PubMed

Visualizations


Asbury's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department